A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
- Status
- COMPLETED
- Phase
- NA
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline
- Status
- TERMINATED
- Phase
- PHASE1
Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
- Status
- COMPLETED
- Phase
- PHASE3
Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI
- Status
- UNKNOWN
- Phase
- PHASE1
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency
- Status
- UNKNOWN
- Phase
- PHASE2
Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE3
Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Treating NSCLC Minimal Stage IV With Curative Intent
- Status
- TERMINATED
- Phase
- PHASE2
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation
- Status
- COMPLETED
- Phase
- PHASE2
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)
- Status
- COMPLETED
- Phase
- PHASE1
LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3